Changeflow GovPing Pharma & Drug Safety Simultaneous gene editing and haploid induction
Routine Notice Added Final

Simultaneous gene editing and haploid induction

Favicon for changeflow.com ChangeBridge: Patent Grants - Biotech (C12N)
Published April 7th, 2026
Detected April 7th, 2026
Email

Summary

USPTO granted patent US12593765B2 to Syngenta Crop Protection AG covering methods for simultaneous gene editing and haploid induction in crops. The patent describes using a transformed haploid inducing line as a parent in plant crosses, where gene editing machinery operates during embryonic development after one set of parental chromosomes is lost. Inventors are Qiudeng Que and Timothy Kelliher.

What changed

USPTO granted patent US12593765B2 to Syngenta Crop Protection AG covering methods for simultaneous gene editing and haploid induction in crops. The patent describes using a transformed haploid inducing line as a parent in plant crosses, where gene editing machinery is delivered during pollination and operates during embryonic development after one set of parental chromosomes is lost, producing at least one haploid progeny with edited genes. The patent contains 10 claims under CPC classification C12N 15/82.

Patent holders should review the claims to understand the scope of protection and ensure their own gene editing and haploid induction technologies do not infringe. This grant confirms intellectual property rights in the agricultural biotechnology space; no compliance deadlines or regulatory obligations are imposed.

Source document (simplified)

← USPTO Patent Grants

Simultaneous gene editing and haploid induction

Grant US12593765B2 Kind: B2 Apr 07, 2026

Assignee

SYNGENTA CROP PROTECTION AG

Inventors

Qiudeng Que, Timothy Kelliher

Abstract

The presently disclosed subject matter relates to using a haploid inducing line (whether existing or created) and transforming the haploid line so that it encodes cellular machinery capable of editing genes. The transformed haploid inducing line is used as a parent in a cross between two plants. During pollination, the parental gametes fuse to form an embryo; and the gene editing machinery is also delivered to the embryo at this time. During embryonic development, one set of parental chromosomes are lost, and the gene editing machinery operates on the remaining set of chromosomes. Thus, at least one haploid progeny with edited genes is produced from the cross.

CPC Classifications

C12N 15/82

Filing Date

2017-12-04

Application No.

16465644

Claims

10

View original document →

Named provisions

Simultaneous gene editing and haploid induction

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12593765B2

Who this affects

Applies to
Agricultural firms Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 1111 Crop Production 3254.1 Biotechnology
Activity scope
Patent Licensing Genetic Engineering
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Agriculture

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.